{"id":923474,"date":"2026-01-05T07:41:31","date_gmt":"2026-01-05T12:41:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/"},"modified":"2026-01-05T07:41:31","modified_gmt":"2026-01-05T12:41:31","slug":"bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/","title":{"rendered":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S."},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nBausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research<\/p>\n<\/li>\n<li>\nBausch + Lomb will also sponsor The Glaucoma Foundation\u2019s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocates<\/p>\n<\/li>\n<li>\nGlaucoma affects about four million people in the United States<sup>1<\/sup><\/li>\n<\/ul>\n<p>VAUGHAN, Ontario&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation\u2019s (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.<\/p>\n<p>\n\u201cCurrently, about four million people in the United States are affected by glaucoma, and this number is only expected to grow as the population ages,\u201d said Andrew Stewart, president, Global Pharmaceuticals and International Consumer, Bausch + Lomb. \u201cOur collaborations with GRF and TGF will advance education and research efforts designed to improve the lives of those affected by glaucoma and encourage everyone to be proactive when it comes to eye health.\u201d<\/p>\n<p>\nAs part of the fundraising challenge with GRF, Bausch + Lomb will match every dollar raised during January, up to $20,000. All proceeds will support critical research for glaucoma, a leading cause of irreversible blindness in the U.S.<sup>1<\/sup><\/p>\n<p>\n\u201cGlaucoma often progresses without noticeable symptoms, making research and improved education vital to saving sight,\u201d said Thomas M. Brunner, president and CEO, Glaucoma Research Foundation. \u201cOur continued partnership with Bausch + Lomb supports our efforts to accelerate the discoveries that can make a real difference for people living with this disease.\u201d<\/p>\n<p>\nLearn more about GRF or make a donation at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glaucoma.org&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=www.glaucoma.org&amp;index=1&amp;md5=e2bd2af9a813c5f9b932add9c54285ed\">www.glaucoma.org<\/a>.<\/p>\n<p>\nTGF\u2019s social media campaign aims to put a human face to the disease, raise awareness and stress the importance of early detection by sharing personal stories from a patient or advocate each day during the month of January.<\/p>\n<p>\n\u201cDue to the chronic, progressive nature of glaucoma, early intervention can mean the difference between saving and losing sight,\u201d said Elena Sturman, president and CEO, The Glaucoma Foundation. \u201cIn partnership with Bausch + Lomb, our campaign will showcase real-world experiences with glaucoma, create greater awareness and bring hope to those affected by this disease.\u201d<\/p>\n<p>\nLearn more about The Glaucoma Foundation at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glaucomafoundation.org&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=www.glaucomafoundation.org&amp;index=2&amp;md5=9a8ac500693979028cca463a37a19845\">www.glaucomafoundation.org<\/a> and follow the organization on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FThe.Glaucoma.Foundation%3F__cft__%255b0%255d%3DAZXqqLg6Jz2AnOVP8r7ktF7ggbDW_VUJydHyhMd07ONd9R19Hqv7eXzQEnFGXZ9eC2RcvsYUBwAhEaHFGyLdQdjRySa5i46j9th47U0AAGmrkj8js7l0xBWk6M-dCP07RHsQQscVyjSGD0W5ApEB5GFlOIYeGSMDsXxV84pmMTBYX4kPbnAXXt4mJoZd8saYisA%26__tn__%3D-UC%252CP-R&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=f196d160a6cb5449288e63f263979548\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Ftheglaucomafoundation%2F%3Fhl%3Den&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=Instagram&amp;index=4&amp;md5=171e6dbe84e5891348f6d4c0a4b6da2a\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F-the-glaucoma-foundation%2Fposts%3Flipi%3Durn%253Ali%253Apage%253Ad_flagship3_company_posts%253BA7Pr2DCqQS6sldj3qZoD9g%253D%253D&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=28210db92d43fc61051f9d9d09f7aa73\">LinkedIn<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FTGF_Glaucoma&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=X&amp;index=6&amp;md5=0e28395f4f3b61d7f113b82a8516b736\">X<\/a> to experience the social media campaign throughout Glaucoma Awareness Month.<\/p>\n<p><b>About Glaucoma<br \/>\n<br \/><\/b>Glaucoma is a chronic, progressive disease that occurs when excessive eye pressure or other causes lead to damage of the optic nerve. The optic nerve is responsible for the communication of information between the eye and brain. Damage to the optic nerve can lead to severe vision loss, and in the worst case, blindness. As the leading cause of irreversible blindness, glaucoma affects about four million people in the United States, but if caught early, it is possible to help slow and potentially prevent vision loss.<sup>1-3<\/sup><\/p>\n<p><b>About Bausch + Lomb<br \/>\n<br \/><\/b>Our mission is simple \u2013 we help people see better to live better, all over the world. For nearly two centuries we\u2019ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we\u2019re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.bausch.com%252F%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489762975076%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DpPGiB1wqFvTfypm1vr987CFdLuMwxF8DcTDzrT0ao50%253D%26reserved%3D0&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=www.bausch.com&amp;index=7&amp;md5=3a4a8dfc67c4278c51f590e337844378\">www.bausch.com<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.facebook.com%252FBauschandLomb%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489762997411%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3Df2pARCHy%252BNYMvTiPATxSt72PANiZtEJrsU1R8eMmMd8%253D%26reserved%3D0&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=Facebook&amp;index=8&amp;md5=516d84ce5a332cd5ec803a23bb82b8c5\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.instagram.com%252Fbauschlomb%252F%253Fhl%253Den%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489763003467%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DpRbp6Zvo4%252FQxmd%252BMPrA3%252F5zl%252B3rr1SrH%252B4ex%252BK3aINw%253D%26reserved%3D0&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=Instagram&amp;index=9&amp;md5=0e2c9d9b083ab853ed03f7cd7c37b1a9\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252F5185%252Fadmin%252F%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489762991335%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3D8Rj%252FOVGvwqZ3UXxzqwiE5orW6voaX8GRJCT4YfTUkEM%253D%26reserved%3D0&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=10&amp;md5=9b4629d69b1afb085fe6cd2c54386b09\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ftwitter.com%252FBauschLomb%26data%3D05%257C02%257CKristy.Marks%2540bausch.com%257Cfbdd2eee03a847254c7808dc2db200aa%257C847856c8738e4dbe9d18a304f99de0e0%257C0%257C0%257C638435489762984265%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DyBmhAao4MLMuKhlW%252FOLvnSmNGoilNOBYDVp4Ir%252F%252F7vg%253D%26reserved%3D0&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=X&amp;index=11&amp;md5=815469ef1ee67816255bd895d762b9ff\">X<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fbauschlomb1&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=YouTube&amp;index=12&amp;md5=b91efe99989c95161434521f44061594\">YouTube<\/a>.<\/p>\n<p><b>About Glaucoma Research Foundation<br \/>\n<br \/><\/b>Glaucoma Research Foundation (GRF) is a national non-profit organization dedicated to finding a cure for glaucoma. GRF funds glaucoma research worldwide and serves as the leading information source for patients and their families. Founded in 1978 in San Francisco, GRF was created to encourage innovative research to find better ways to care for people with glaucoma \u2014 the leading cause of preventable blindness. Since its inception, GRF has invested more than $90 million to fund breakthrough research to better understand, detect, and treat glaucoma.<\/p>\n<p><b>About The Glaucoma Foundation<br \/>\n<br \/><\/b>Since 1984, The Glaucoma Foundation has worked to identify, encourage, and fund scientific research into the potentially blinding disease of glaucoma, with the goal of eradicating vision loss and blindness from glaucoma. Through education and outreach, we strive to be a valuable resource to improve the lives of those affected by the disease.<\/p>\n<p><b>References<\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nEhrlich JR, Burke-Conte Z, Wittenborn JS, et al. Prevalence of Glaucoma Among US Adults in 2022. <i>JAMA Ophthalmol<\/i>. 2024;142(11):1046\u20131053. doi:10.1001\/jamaophthalmol.2024.3884<\/p>\n<\/li>\n<li>\nJohn Hopkins. Glaucoma. Retrieved from <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hopkinsmedicine.org%2Fhealth%2Fconditions-and-diseases%2Fglaucoma&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.hopkinsmedicine.org%2Fhealth%2Fconditions-and-diseases%2Fglaucoma&amp;index=13&amp;md5=f65353013f6269bf500a8a82238ddbfe\">https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/glaucoma<\/a>. Reviewed on Nov. 7, 2025.<\/p>\n<\/li>\n<li>\nNational Eye Institute. Glaucoma and Eye Pressure. Retrieved from <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nei.nih.gov%2Flearn-about-eye-health%2Feye-conditions-and-diseases%2Fglaucoma%2Fglaucoma-and-eye-pressure&amp;esheet=54386969&amp;newsitemid=20260105643250&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.nei.nih.gov%2Flearn-about-eye-health%2Feye-conditions-and-diseases%2Fglaucoma%2Fglaucoma-and-eye-pressure&amp;index=14&amp;md5=9d180b41376cea5f90f923dffcc4b901\">https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/glaucoma\/glaucoma-and-eye-pressure<\/a>. Reviewed on Nov. 7, 2025.<\/p>\n<\/li>\n<\/ol>\n<p><i>\u00a9 2025 Bausch + Lomb.<\/i><\/p>\n<p><i>BLNP.0137.USA.25<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260105643250\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260105643250\/en\/<\/a><\/span><\/p>\n<p><b>Bausch + Lomb Media Contact<br \/>\n<\/b><br \/>Caryn Marshall<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:caryn.marshall@bausch.com\">caryn.marshall@bausch.com<br \/>\n<\/a><br \/>(908) 493-1381<\/p>\n<p><b>Glaucoma Research Foundation Media Contact:<br \/>\n<\/b><br \/>Andrew J. Jackson<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ajackson@glaucoma.org\">ajackson@glaucoma.org<br \/>\n<\/a><br \/>(415) 986-3162<\/p>\n<p><b>The Glaucoma Foundation Media Contact:<br \/>\n<\/b><br \/>Gabrielle Bamberger<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:gbprbiz@verizon.net\">gbprbiz@verizon.net<br \/>\n<\/a><br \/>917-273-7382<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Social Media Social Activism Communications Optical General Health Philanthropy Women Seniors Men Fund Raising Foundation Other Philanthropy Consumer Health Medical Supplies<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260105643250\/en\/1668940\/3\/Bausch_Lomb_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + Lomb will also sponsor The Glaucoma Foundation\u2019s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocates Glaucoma affects about four million people in the United States1 VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-923474","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + Lomb will also sponsor The Glaucoma Foundation\u2019s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocates Glaucoma affects about four million people in the United States1 VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness &hellip; Continue reading &quot;Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-05T12:41:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.\",\"datePublished\":\"2026-01-05T12:41:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/\"},\"wordCount\":934,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/\",\"name\":\"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-01-05T12:41:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/","og_locale":"en_US","og_type":"article","og_title":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk","og_description":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + Lomb will also sponsor The Glaucoma Foundation\u2019s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocates Glaucoma affects about four million people in the United States1 VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211; Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness &hellip; Continue reading \"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-05T12:41:31+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.","datePublished":"2026-01-05T12:41:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/"},"wordCount":934,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/","name":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-01-05T12:41:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260105643250r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bausch-lomb-partners-with-glaucoma-research-foundation-and-the-glaucoma-foundation-to-address-a-leading-cause-of-irreversible-blindness-in-the-u-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=923474"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=923474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=923474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=923474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}